Skip to main content

Headlines

Oracle's 8% Bond Yields Are an Oracle Problem, Not an AI Problem
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Hannity - Tuesday, September 29
posted:
by: Fox Video
#channels:: #All, #News, #Fox, #Video, #FoxVideo
European Markets Seen Rising On Wednesday
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Special Report with Bret Baier - Tuesday, September 29
posted:
by: Fox Video
#channels:: #All, #News, #Fox, #Video, #FoxVideo
Roche Unveils Newborn Screening Test For 3 Genetic Conditions Of SMA, SCID, Sickle Cell Disease
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
TomTom Expands Collaboration With Microsoft Fabric To Power AI Agents With Real-world Context
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
CNBC Daily Open: AI will be marking its own homework — for now
posted:
by: CNBC World News
#channels:: #All, #News, #World, #CNBC, #CNBCWorldNews
Suspect in alleged plot against British base called police before arrest, UK media report
posted:
by: CNN Most Recent
#channels:: #All, #World, #Latest, #News, #CNN
AbbVIe's Zumilokibart Meets Phase 2 Goal In Atopic Dermatitis Study
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Takeda's Zasocitinib Shows Superior Skin Clearance In Phase 3 Psoriasis Trial
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Galderma Reports Three-Year Nemluvio Data In Moderate-to-Severe Atopic Dermatitis
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Scientists deliver ‘starkest warning yet’ of profound changes sweeping the planet’s oceans
posted:
by: CNN Most Recent
#channels:: #All, #World, #Latest, #News, #CNN
Galderma's Nemluvio Shows Sustained Three-Year Benefits In Atopic Dermatitis
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Dyne Reports One-Year Z-Basivarsen Data Showing Functional Improvements In DM1
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Genentech: FDA Grants Priority Review To Fenebrutinib NDA For Relapsing And Primary Progressive MS
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks